Table 2
Open in new tab

Procedural characteristics and outcome

N = 18
Epicardial access (%)22
Number of inducible ventricular tachycardia morphologies (n)1.4 ± 1.3
Procedural duration (min)157 ± 31
Fluoroscopy time (min)5.2 ± 4.0
Fluoroscopy dose (µGy m2)4627 ± 9557
RF applications (n)12 ± 7
PF applications (n)8 ± 9
Post-ablation ventricular arrhythmia non-inducibility (%)89
Ventricular-arrhythmia-free survival at 3 months (%)78
N = 18
Epicardial access (%)22
Number of inducible ventricular tachycardia morphologies (n)1.4 ± 1.3
Procedural duration (min)157 ± 31
Fluoroscopy time (min)5.2 ± 4.0
Fluoroscopy dose (µGy m2)4627 ± 9557
RF applications (n)12 ± 7
PF applications (n)8 ± 9
Post-ablation ventricular arrhythmia non-inducibility (%)89
Ventricular-arrhythmia-free survival at 3 months (%)78
Table 2
Open in new tab

Procedural characteristics and outcome

N = 18
Epicardial access (%)22
Number of inducible ventricular tachycardia morphologies (n)1.4 ± 1.3
Procedural duration (min)157 ± 31
Fluoroscopy time (min)5.2 ± 4.0
Fluoroscopy dose (µGy m2)4627 ± 9557
RF applications (n)12 ± 7
PF applications (n)8 ± 9
Post-ablation ventricular arrhythmia non-inducibility (%)89
Ventricular-arrhythmia-free survival at 3 months (%)78
N = 18
Epicardial access (%)22
Number of inducible ventricular tachycardia morphologies (n)1.4 ± 1.3
Procedural duration (min)157 ± 31
Fluoroscopy time (min)5.2 ± 4.0
Fluoroscopy dose (µGy m2)4627 ± 9557
RF applications (n)12 ± 7
PF applications (n)8 ± 9
Post-ablation ventricular arrhythmia non-inducibility (%)89
Ventricular-arrhythmia-free survival at 3 months (%)78
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close